(Q36182981)

12 August 2017

1 reference

title

Comorbidity indices in hematopoietic stem cell transplantation: a new report card (English)

1 reference

12 August 2017

1 reference

Alamo J

1

1 reference

12 August 2017

Shahjahan M

2

1 reference

12 August 2017

Lazarus HM

3

1 reference

12 August 2017

de Lima M

4

1 reference

12 August 2017

Giralt SA

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Bone Marrow Transplantation

12 August 2017

1 reference

12 August 2017

36

1 reference

12 August 2017

6

1 reference

12 August 2017

475-479

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705041

12 August 2017

0 references

cites work

The pre-therapeutic classification of co-morbidity in chronic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Is there an upper age limit for bone marrow transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Are predictive factors clinically useful in bone marrow transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Predictive value of pulmonary function tests before marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Pulmonary function testing prior to hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Veno-occlusive disease of the liver after hemopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Cumulative illness rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

How to measure comorbidity. a critical review of available methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Measuring comorbidity in older cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Measurement and impact of comorbidity in older cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

The relationship between disease and function and perceived health in very frail elders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Systematic evaluation of rating scales for impairment and disability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Review of outcome measures used in adult critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

Predictive value of left ventricular ejection fraction in stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Cardiac systolic function before and after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Clinical investigations in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Adapting the Charlson Comorbidity Index for use in patients with ESRD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

The development and validation of a comorbidity index for prostate cancer among Black men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705041

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705041

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference